Clinical evaluation In the health outcome of patients with bronchial asthma at the first visit and unscheduled visit with budesonide/formoterol therapy
- Conditions
- bronchial asthma
- Registration Number
- JPRN-UMIN000028486
- Lead Sponsor
- Hiroshima Allergy and Pulmonary Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Not provided
Following are exclusion criteria 1)Patient with the drug allergy 2)Infection in the absence of effective antimicrobial agents,patients with deep mycosis 3)Patients with tuberculous disease,or respiratory infection 4)Patients with abnormal chest X-ray image 5)Patients with respiratory disease and other respiratory infections in 8 weeks before inclusion 6)Patients are using the b-blockers, including eye drops or patients with systemic corticosteroids to less than 30 days 7)Patients with serious complications 8)Smoking history of 10 pack years or more and with less than 6 months or by non smoking 9)Patients with pregnancy,or who hope for a pregnancy 10)Patients were deemed inappropriate research attending physician is incorporated into this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement ratio (%) for the health outcome (degree of suffering and trouble; VAS value) by BUD/FM
- Secondary Outcome Measures
Name Time Method Comparison of the followings between at the baseline and at 4 weeks; -ACQ score -FeNO -Airway resistance with IOS -%FEV1.0 -Frequency of SABA use